A detailed history of North Crest Asset Manangement, LLC transactions in Amgen Inc stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 97,096 shares of AMGN stock, worth $31.3 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares
97,096
Previous 95,531 1.64%
Holding current value
$31.3 Million
Previous $29.8 Million 4.81%
% of portfolio
0.98%
Previous 1.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$309.38 - $337.38 $484,179 - $527,999
1,565 Added 1.64%
97,096 $31.3 Million
Q2 2024

Jul 16, 2024

BUY
$262.75 - $319.31 $612,470 - $744,311
2,331 Added 2.5%
95,531 $29.8 Million
Q1 2024

Apr 15, 2024

BUY
$268.87 - $324.56 $447,668 - $540,392
1,665 Added 1.82%
93,200 $26.5 Million
Q4 2023

Jan 30, 2024

SELL
$255.7 - $288.46 $197,656 - $222,979
-773 Reduced 0.84%
91,535 $26.4 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $142,559 - $176,991
-652 Reduced 0.7%
92,308 $24.8 Million
Q2 2023

Jul 21, 2023

BUY
$214.27 - $253.37 $201,413 - $238,167
940 Added 1.02%
92,960 $20.6 Million
Q1 2023

Apr 25, 2023

BUY
$225.79 - $275.2 $4.15 Million - $5.06 Million
18,381 Added 24.96%
92,020 $22.2 Million
Q4 2022

Feb 01, 2023

SELL
$229.03 - $291.01 $417,750 - $530,802
-1,824 Reduced 2.42%
73,639 $19.3 Million
Q3 2022

Oct 17, 2022

BUY
$224.46 - $253.15 $443,757 - $500,477
1,977 Added 2.69%
75,463 $17 Million
Q2 2022

Jul 18, 2022

BUY
$230.71 - $256.74 $64,829 - $72,143
281 Added 0.38%
73,486 $17.9 Million
Q1 2022

Apr 18, 2022

BUY
$219.27 - $242.57 $924,442 - $1.02 Million
4,216 Added 6.11%
73,205 $17.7 Million
Q4 2021

Feb 09, 2022

BUY
$198.88 - $227.6 $13.7 Million - $15.7 Million
68,989 New
68,989 $15.5 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track North Crest Asset Manangement, LLC Portfolio

Follow North Crest Asset Manangement, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Crest Asset Manangement, LLC with notifications on news.